Back to FDA Applications sponsored by GLAXOSMITHKLINE

FDA Drug Application 020250 by GLAXOSMITHKLINE

Application Number020250
Application Type New Drug Application
Sponsor ApplicantGLAXOSMITHKLINE
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan CodeV


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP07/24/1992N       
AP012/2/1992SCM       
AP08/6/1997SLR       
AP02/12/1993SLR       
AP09/23/1993SCP       
AP08/6/1997SLR       
AP08/1/2002SLR2191007   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20250slr007,008ltr.pdf 8/1/2002
AP08/1/2002SLR2192007   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20250s7s8lbl.pdf 8/1/2002
AP08/1/2002SLR2193008   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20250slr007,008ltr.pdf 8/1/2002
AP08/1/2002SLR2194008   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20250s7s8lbl.pdf 8/1/2002




Back to FDA Applications sponsored by GLAXOSMITHKLINE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.